Suchergebnisse - "Entezari-Maleki, Taher"

PubPharm (98)

41

SARS-CoV-2: Receptor and Co-receptor Tropism Probability

enthalten in: Current microbiology | 2022

von Eslami, N. | Aghbash, P. | Shamekh, A. | +4

42

SARS-CoV-2: Receptor and Co-receptor Tropism Probability

enthalten in: Current microbiology | 2022

von Eslami, N. | Aghbash, P. | Shamekh, A. | +4

43

Investigational antiviral drugs for the treatment of COVID-19 patients

enthalten in: Archives of virology | 2022

von Beheshtirouy, S. | Khani, E. | Khiali, S. | +1

44

SARS-CoV-2 and probable lung cancer risk

enthalten in: BioImpacts : BI | 2022

von Khiali, S. | Rezagholizadeh, A. | Entezari-Maleki, T.

45

Hypertensive Crisis Following COVID‐19 Vaccination

enthalten in: The Journal of Clinical Pharmacology | 2022

von Khani, E. | Entezari‐Maleki, T.

46

New Variants of SARS‐CoV‐2 and Next Generation of COVID‐19 Treatments

enthalten in: The Journal of Clinical Pharmacology | 2022

von Khiali, S. | Entezari‐Maleki, T.

47

Potential pharmacologic treatments for COVID-19 smell and taste loss : A comprehensive review

enthalten in: European journal of pharmacology | 2021

von Khani, E. | Khiali, S. | Beheshtirouy, S. | +1

48

Evaluation of the activated partial thromboplastin time and its influential factors in ischemic heart disease patients under heparin treatment

enthalten in: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis | 2021

von Rezagholizadeh, A. | Adib, Z. | Entezari-Maleki, T.

49

Therapeutic Application of Corticosteroids in COVID-19 : A Focus on Optimum Dose and Duration of Therapy

enthalten in: Journal of clinical pharmacology | 2021

von Khiali, S. | Entezari-Maleki, T.

CommentOn: BMC Infect Dis. 2021 Apr 10;21(1):337. - PMID 33838657

50

Vitamin supplementation as a potential adjunctive therapeutic approach for COVID-19: biological and clinical plausibility

enthalten in: Journal of basic and clinical physiology and pharmacology | 2021

von Daei Sorkhabi, A. | Sarkesh, A. | Daei Sorkhabi, A. | +3